NASDAQ:CGABL Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Stock Price, News & Analysis → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free CGABL Stock Alerts $18.60 +0.22 (+1.20%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$18.40▼$18.6050-Day Range$18.06▼$20.5552-Week Range$15.60▼$20.75Volume7,195 shsAverage Volume21,509 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsSEC FilingsShort InterestSocial Media Get Carlyle Group Inc. 4.625% Subordinated Notes due 2061 alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock (NASDAQ:CGABL)biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company’s first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs tRead More CGABL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CGABL Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive CGABL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carlyle Group Inc. 4.625% Subordinated Notes due 2061 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 2/15 Dividend1/31/2024Dividend Payable2/15/2024Ex-Dividend for 5/15 Dividend4/30/2024Today5/04/2024Dividend Payable5/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Sector-- Industry - Sub-IndustryN/A Current SymbolNASDAQ:CGABL CUSIPN/A CIK1527166 WebN/A PhoneN/AFaxN/AEmployees686Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key CompetitorsAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028NASDAQ:ABLLLAbrdn Global Infrastructure Income FundNYSE:ASGIAimei Health TechnologyNASDAQ:AFJKRAlphaTime AcquisitionNASDAQ:ATMCRArgo Blockchain plc 8.75% Senior Notes due 2026NASDAQ:ARBKLView All Competitors CGABL Stock Analysis - Frequently Asked Questions How have CGABL shares performed in 2024? Carlyle Group Inc. 4.625% Subordinated Notes due 2061's stock was trading at $20.59 on January 1st, 2024. Since then, CGABL stock has decreased by 9.7% and is now trading at $18.60. View the best growth stocks for 2024 here. Are investors shorting Carlyle Group Inc. 4.625% Subordinated Notes due 2061? Carlyle Group Inc. 4.625% Subordinated Notes due 2061 saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 8,100 shares, a decrease of 47.7% from the March 31st total of 15,500 shares. Based on an average daily trading volume, of 20,900 shares, the short-interest ratio is currently 0.4 days. View Carlyle Group Inc. 4.625% Subordinated Notes due 2061's Short Interest. How often does Carlyle Group Inc. 4.625% Subordinated Notes due 2061 pay dividends? What is the dividend yield for Carlyle Group Inc. 4.625% Subordinated Notes due 2061? Carlyle Group Inc. 4.625% Subordinated Notes due 2061 announced a quarterly dividend on Tuesday, April 30th. Stockholders of record on Wednesday, May 1st will be paid a dividend of $0.2891 per share on Wednesday, May 15th. This represents a $1.16 dividend on an annualized basis and a yield of 6.22%. The ex-dividend date of this dividend is Tuesday, April 30th. This is a boost from the stock's previous quarterly dividend of $0.29. Read our dividend analysis for CGABL. How do I buy shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061? Shares of CGABL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CGABL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.